Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
3 Buffett-Type Stocks to Buy Right Now
02:37pm, Wednesday, 25'th Jan 2023 The Motley Fool
These stocks are good value buys for the long haul.
3 Buffett-Type Stocks to Buy Right Now
09:37am, Wednesday, 25'th Jan 2023
These stocks are good value buys for the long haul.
Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%
05:15pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
Iovance (IOVA) to acquire worldwide rights to an IL-2 product already approved by FDA for two cancer indications. The deal is expected to close by first-quarter 2023.
3 Top Dividend Stocks to Maximize Your Retirement Income
02:10pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco
5 Best and Worst Performing Health Care Stocks in December 2022
10:51pm, Monday, 23'rd Jan 2023
Despite inflation making it hard for the healthcare industry to manage its operating costs, there are a few positives that make this sector attractive to investors.
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
10:50pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Bristol Myers Squibb (BMY) closed the most recent trading day at $73.26, moving -1.2% from the previous trading session.
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
03:26pm, Thursday, 19'th Jan 2023 Zacks Investment Research
Roche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating early-stage hepatocellular carcinoma, meets its primary endpoint.
bluebird (BLUE) Stock Dives on Public Offering of Common Stock
03:20pm, Thursday, 19'th Jan 2023 Zacks Investment Research
bluebird (BLUE) to issue secondary shares, diluting its current shareholder base. The company plans to raise $120 million in gross proceeds from this issue.
5 Stocks You Can Confidently Invest $500 in Right Now
10:49am, Thursday, 19'th Jan 2023 The Motley Fool
Any investor with $500 can buy these stocks with conviction.
5 Stocks You Can Confidently Invest $500 in Right Now
05:49am, Thursday, 19'th Jan 2023
Any investor with $500 can buy these stocks with conviction.
Nicholas Ward's Dividend Growth Portfolio: December/Full Year 2022 Review
04:46pm, Wednesday, 18'th Jan 2023
My passive income was up by 46.50% on a year-over-year basis during December. For the full-year in 2022, my passive income rose by 23.73%.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
02:10pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate i
Why Bristol Myers Squibb Is The Better Buy From U.S. Large Cap Pharma
02:04am, Wednesday, 18'th Jan 2023
While foreign competitors Novartis and Roche scored better than Bristol Myers in my recent pipeline analysis, BMY is the best US option. This article will revisit the metrics that allowed BMY to beat
My Dividend Growth Portfolio - Q4 2022 Summary
01:23am, Wednesday, 18'th Jan 2023
In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its
Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know
10:50pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
Bristol Myers Squibb (BMY) closed at $72.31 in the latest trading session, marking a -0.28% move from the prior day.
